“Efficacy of Spesolimab for the Treatment of GPP Flares across Prespecified Patient Subgroups in the Effisayil 1 Study”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s121. https://doi.org/10.25251/skin.7.supp.121.